AR120398A1 - Lavados de salinidad elevada durante cromatografía de intercambio catiónico para eliminar impurezas relacionadas con el producto - Google Patents
Lavados de salinidad elevada durante cromatografía de intercambio catiónico para eliminar impurezas relacionadas con el productoInfo
- Publication number
- AR120398A1 AR120398A1 ARP200103071A ARP200103071A AR120398A1 AR 120398 A1 AR120398 A1 AR 120398A1 AR P200103071 A ARP200103071 A AR P200103071A AR P200103071 A ARP200103071 A AR P200103071A AR 120398 A1 AR120398 A1 AR 120398A1
- Authority
- AR
- Argentina
- Prior art keywords
- cation exchange
- product related
- related impurities
- exchange chromatography
- high salinity
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
- C07K16/06—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies from serum
- C07K16/065—Purification, fragmentation
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
- C07K1/14—Extraction; Separation; Purification
- C07K1/16—Extraction; Separation; Purification by chromatography
- C07K1/18—Ion-exchange chromatography
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01D—SEPARATION
- B01D15/00—Separating processes involving the treatment of liquids with solid sorbents; Apparatus therefor
- B01D15/08—Selective adsorption, e.g. chromatography
- B01D15/26—Selective adsorption, e.g. chromatography characterised by the separation mechanism
- B01D15/36—Selective adsorption, e.g. chromatography characterised by the separation mechanism involving ionic interaction, e.g. ion-exchange, ion-pair, ion-suppression or ion-exclusion
- B01D15/361—Ion-exchange
- B01D15/362—Cation-exchange
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01D—SEPARATION
- B01D15/00—Separating processes involving the treatment of liquids with solid sorbents; Apparatus therefor
- B01D15/08—Selective adsorption, e.g. chromatography
- B01D15/26—Selective adsorption, e.g. chromatography characterised by the separation mechanism
- B01D15/38—Selective adsorption, e.g. chromatography characterised by the separation mechanism involving specific interaction not covered by one or more of groups B01D15/265 and B01D15/30 - B01D15/36, e.g. affinity, ligand exchange or chiral chromatography
- B01D15/3804—Affinity chromatography
- B01D15/3809—Affinity chromatography of the antigen-antibody type, e.g. protein A, G or L chromatography
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01D—SEPARATION
- B01D15/00—Separating processes involving the treatment of liquids with solid sorbents; Apparatus therefor
- B01D15/08—Selective adsorption, e.g. chromatography
- B01D15/42—Selective adsorption, e.g. chromatography characterised by the development mode, e.g. by displacement or by elution
- B01D15/424—Elution mode
- B01D15/426—Specific type of solvent
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01D—SEPARATION
- B01D61/00—Processes of separation using semi-permeable membranes, e.g. dialysis, osmosis or ultrafiltration; Apparatus, accessories or auxiliary operations specially adapted therefor
- B01D61/14—Ultrafiltration; Microfiltration
- B01D61/145—Ultrafiltration
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
- C07K16/46—Hybrid immunoglobulins
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
- C07K16/46—Hybrid immunoglobulins
- C07K16/468—Immunoglobulins having two or more different antigen binding sites, e.g. multifunctional antibodies
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01D—SEPARATION
- B01D2315/00—Details relating to the membrane module operation
- B01D2315/16—Diafiltration
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/20—Immunoglobulins specific features characterized by taxonomic origin
- C07K2317/21—Immunoglobulins specific features characterized by taxonomic origin from primates, e.g. man
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/30—Immunoglobulins specific features characterized by aspects of specificity or valency
- C07K2317/31—Immunoglobulins specific features characterized by aspects of specificity or valency multispecific
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/60—Immunoglobulins specific features characterized by non-natural combinations of immunoglobulin fragments
- C07K2317/64—Immunoglobulins specific features characterized by non-natural combinations of immunoglobulin fragments comprising a combination of variable region and constant region components
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Molecular Biology (AREA)
- Immunology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Genetics & Genomics (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Biophysics (AREA)
- Biochemistry (AREA)
- Analytical Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Water Supply & Treatment (AREA)
- Engineering & Computer Science (AREA)
- Peptides Or Proteins (AREA)
- Treatment Of Liquids With Adsorbents In General (AREA)
- Apparatus Associated With Microorganisms And Enzymes (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201962931874P | 2019-11-07 | 2019-11-07 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AR120398A1 true AR120398A1 (es) | 2022-02-09 |
Family
ID=73598212
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ARP200103071A AR120398A1 (es) | 2019-11-07 | 2020-11-05 | Lavados de salinidad elevada durante cromatografía de intercambio catiónico para eliminar impurezas relacionadas con el producto |
Country Status (14)
| Country | Link |
|---|---|
| US (1) | US20220372071A1 (https=) |
| EP (1) | EP4055042A1 (https=) |
| JP (2) | JP2022554283A (https=) |
| KR (1) | KR20220092958A (https=) |
| CN (1) | CN114651007A (https=) |
| AR (1) | AR120398A1 (https=) |
| AU (1) | AU2020377919A1 (https=) |
| BR (1) | BR112022008782A2 (https=) |
| CA (1) | CA3160208A1 (https=) |
| CL (2) | CL2022001169A1 (https=) |
| IL (1) | IL292602A (https=) |
| MX (1) | MX2022005594A (https=) |
| TW (2) | TWI878377B (https=) |
| WO (1) | WO2021091933A1 (https=) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP4263597A2 (en) * | 2020-12-18 | 2023-10-25 | Kiniksa Pharmaceuticals, Ltd. | Protein compositions and methods for producing and using the same |
Family Cites Families (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU9034298A (en) * | 1997-08-25 | 1999-03-16 | Walter H. Runkis | A simple, environmentally benign, method for purifying protein |
| ES2533266T5 (es) * | 2007-10-30 | 2018-04-18 | Genentech, Inc. | Purificación de anticuerpos mediante cromatografía de intercambio catiónico |
| US20120282654A1 (en) * | 2009-04-29 | 2012-11-08 | Schering Corporation | Antibody purification |
| WO2012125735A1 (en) * | 2011-03-15 | 2012-09-20 | Abott Laboratories | An integrated approach to the isolation and purification of antibodies |
| CN104628846B (zh) * | 2013-11-06 | 2019-12-06 | 三生国健药业(上海)股份有限公司 | 重组蛋白质的纯化方法 |
| WO2015198320A1 (en) * | 2014-06-24 | 2015-12-30 | Insight Biopharmaceuticals Ltd. | Methods of purifying antibodies |
| EP3177643B1 (en) * | 2014-08-04 | 2019-05-08 | F.Hoffmann-La Roche Ag | Bispecific t cell activating antigen binding molecules |
| EP3204415B1 (en) * | 2014-10-09 | 2020-06-17 | EngMab Sàrl | Bispecific antibodies against cd3epsilon and ror1 |
| JP6699085B2 (ja) * | 2015-03-25 | 2020-05-27 | 東ソー株式会社 | Fc結合性タンパク質の精製方法 |
| EP4549463A3 (en) * | 2016-06-17 | 2025-07-30 | F. Hoffmann-La Roche AG | Purification of multispecific antibodies |
| JP2020525445A (ja) * | 2017-06-21 | 2020-08-27 | セファロン・インコーポレイテッドCephalon,Incorporated | カチオン交換クロマトグラフィーの洗浄緩衝液 |
| CN110305217B (zh) * | 2018-03-27 | 2022-03-29 | 广州爱思迈生物医药科技有限公司 | 双特异性抗体及其应用 |
-
2020
- 2020-11-04 BR BR112022008782A patent/BR112022008782A2/pt unknown
- 2020-11-04 MX MX2022005594A patent/MX2022005594A/es unknown
- 2020-11-04 EP EP20812495.8A patent/EP4055042A1/en active Pending
- 2020-11-04 CA CA3160208A patent/CA3160208A1/en active Pending
- 2020-11-04 US US17/773,892 patent/US20220372071A1/en active Pending
- 2020-11-04 IL IL292602A patent/IL292602A/en unknown
- 2020-11-04 WO PCT/US2020/058774 patent/WO2021091933A1/en not_active Ceased
- 2020-11-04 AU AU2020377919A patent/AU2020377919A1/en active Pending
- 2020-11-04 KR KR1020227018752A patent/KR20220092958A/ko active Pending
- 2020-11-04 JP JP2022525320A patent/JP2022554283A/ja active Pending
- 2020-11-04 CN CN202080077533.3A patent/CN114651007A/zh active Pending
- 2020-11-05 AR ARP200103071A patent/AR120398A1/es unknown
- 2020-11-06 TW TW109138883A patent/TWI878377B/zh active
- 2020-11-06 TW TW114107974A patent/TW202523676A/zh unknown
-
2022
- 2022-05-04 CL CL2022001169A patent/CL2022001169A1/es unknown
-
2024
- 2024-06-14 CL CL2024001792A patent/CL2024001792A1/es unknown
-
2025
- 2025-11-14 JP JP2025195036A patent/JP2026048656A/ja active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| US20220372071A1 (en) | 2022-11-24 |
| CL2024001792A1 (es) | 2024-11-08 |
| CA3160208A1 (en) | 2021-05-14 |
| IL292602A (en) | 2022-07-01 |
| BR112022008782A2 (pt) | 2022-07-26 |
| CL2022001169A1 (es) | 2023-01-27 |
| WO2021091933A1 (en) | 2021-05-14 |
| TW202132323A (zh) | 2021-09-01 |
| MX2022005594A (es) | 2022-06-09 |
| EP4055042A1 (en) | 2022-09-14 |
| TW202523676A (zh) | 2025-06-16 |
| JP2022554283A (ja) | 2022-12-28 |
| JP2026048656A (ja) | 2026-03-17 |
| KR20220092958A (ko) | 2022-07-04 |
| AU2020377919A1 (en) | 2022-06-16 |
| CN114651007A (zh) | 2022-06-21 |
| TWI878377B (zh) | 2025-04-01 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IN2014MU00118A (https=) | ||
| CL2020003254A1 (es) | Procedimiento para la deshidratación de agua fangosa acuosa | |
| IL278932A (en) | Process for the synthesis of (S)-3-amino-4-(difluoromethylnyl)cyclopent-1-ene-1-carboxylic acid | |
| MY199218A (en) | Water treatment of lipid material | |
| MX2016016479A (es) | Metodo para producir un pentapeptido sintetico. | |
| IL281761A (en) | Process of making calcium alpha-ketoglutarate | |
| EA201792640A1 (ru) | Устойчивые к действию протеазы липидированные аналоги glp-1 | |
| AR120398A1 (es) | Lavados de salinidad elevada durante cromatografía de intercambio catiónico para eliminar impurezas relacionadas con el producto | |
| PL3823952T3 (pl) | Oczyszczanie kwasu lewulinowego | |
| EA201790613A1 (ru) | Триазольные соединения в качестве блокаторов кальциевых каналов т-типа | |
| MX375894B (es) | Uso de acido alcanosulfonico para limpieza en las industrias azucareras. | |
| FR3050942B1 (fr) | Procede de purification d'acide chlorhydrique | |
| MX381459B (es) | Metodo de manufactura de proteina. | |
| MY207512A (en) | Process for manufacturing alkanesulfonic acids | |
| MX2017012027A (es) | Desaminacion de nucleosidos organofosforados. | |
| SG11202101575TA (en) | Process for the production of high purity isobutylene | |
| MX2019005785A (es) | Proceso para la purificacion de 1-(4-clorofenil)pirazol-3-ol. | |
| WO2016202808A3 (en) | NEW SYNTHESIS OF TAPENTADOL-HCl INTERMEDIATES | |
| MX2020010343A (es) | Proceso para la purificacion de biocomposiciones complejas. | |
| ZA202205211B (en) | Apparatus for purifying water | |
| HUE064510T2 (hu) | Eljárás N-alkil-hidroxilammónium sókat tartalmazó keverék tisztítására | |
| EP3851446A4 (en) | PEPTIDE PURIFICATION PROCESS USING A SULFONATE COMPOUND | |
| CL2022001168A1 (es) | Acondicionamiento de la carga con salinidad elevada durante la cromatografía de intercambio catiónico para eliminar impurezas relacionadas del producto | |
| PL3793971T3 (pl) | Optymalizacja systemu odzyskiwania 2-etyloheksanolu za pomocą intensyfikacji procesu | |
| EP3539636A4 (en) | METHOD FOR CLEANING WASTE ACID ACID |